Published in J Biol Chem on June 05, 1998
Neuroinflammatory processes in Alzheimer's disease. J Neural Transm (Vienna) (2010) 1.73
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediators Inflamm (2013) 1.12
Catestatin: a multifunctional peptide from chromogranin A. Regul Pept (2010) 1.05
Chromogranin A and the tumor microenvironment. Cell Mol Neurobiol (2010) 0.97
Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases. Exp Neurobiol (2015) 0.80
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation (1995) 2.91
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J Biol Chem (1987) 2.73
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci U S A (1985) 2.72
Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell (1986) 2.38
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol (2000) 2.18
Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. Eur Heart J (1999) 2.12
Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. Antimicrob Agents Chemother (1984) 2.01
Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J (2002) 1.98
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest (1997) 1.86
The many faces of semaphorins: from development to pathology. Cell Mol Life Sci (2009) 1.76
The cytoskeleton as a barrier to exocytosis in secretory cells. J Exp Biol (1988) 1.75
Anti-alpha-fodrin inhibits secretion from permeabilized chromaffin cells. Nature (1987) 1.71
Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res (1988) 1.70
Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells. EMBO J (2001) 1.67
The participation of annexin II (calpactin I) in calcium-evoked exocytosis requires protein kinase C. J Cell Biol (1991) 1.64
Regulated exocytosis in chromaffin cells. A potential role for a secretory granule-associated ARF6 protein. J Biol Chem (1997) 1.54
The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci (2007) 1.51
Regulated exocytosis in chromaffin cells. Translocation of ARF6 stimulates a plasma membrane-associated phospholipase D. J Biol Chem (1998) 1.41
Characterization of hormone and protein release from alpha-toxin-permeabilized chromaffin cells in primary culture. J Biol Chem (1986) 1.38
p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene (2009) 1.35
Biochemistry of the chromogranin A protein family. Biochem J (1989) 1.35
Peripheral actin filaments control calcium-mediated catecholamine release from streptolysin-O-permeabilized chromaffin cells. Eur J Cell Biol (1988) 1.32
Exocytosis in chromaffin cells. Possible involvement of the heterotrimeric GTP-binding protein G(o). J Biol Chem (1993) 1.31
Paradoxical enhancement of S-adenosylmethionine decarboxylase in rat tissues following administration of the specific inhibitor methyl glyoxal bis(guanylhydrazone). Biochem Biophys Res Commun (1973) 1.27
Chromaffin cell calcium channel kinetics measured isotopically through fast calcium, strontium, and barium fluxes. J Biol Chem (1987) 1.27
Reorganization of alpha-fodrin induced by stimulation in secretory cells. Nature (1985) 1.25
Presence of three pertussis toxin substrates and Go alpha immunoreactivity in both plasma and granule membranes of chromaffin cells. FEBS Lett (1987) 1.24
Loss of proteins from digitonin-permeabilized adrenal chromaffin cells essential for exocytosis. J Biol Chem (1987) 1.23
A role for phospholipase D1 in neurotransmitter release. Proc Natl Acad Sci U S A (2001) 1.20
Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Res (2000) 1.20
COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat in human microglial cells. J Biol Chem (1997) 1.18
Annexin II in exocytosis: catecholamine secretion requires the translocation of p36 to the subplasmalemmal region in chromaffin cells. J Cell Biol (1996) 1.18
Specific inhibition of the enzymic decarboxylation of S-adenosylmethionine by methylglyoxal bis(guanylhydrazone) and related substances. Biochem J (1974) 1.15
Secretion from chromaffin cells is controlled by chromogranin A-derived peptides. Proc Natl Acad Sci U S A (1988) 1.15
Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin. J Hosp Infect (1986) 1.13
A reassessment of guanine nucleotide effects on catecholamine secretion from permeabilized adrenal chromaffin cells. J Biol Chem (1989) 1.13
Interhemispheric functional relationships in auditory agnosia. An analysis of the preconditions and a conceptual model. Brain Lang (1978) 1.12
Immunocytochemical study of microtubules in chromaffin cells in culture and evidence that tubulin is not an integral protein of the chromaffin granule membrane. J Neurochem (1981) 1.11
Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor. Proc Natl Acad Sci U S A (1984) 1.10
Identification of a plasma membrane-associated guanine nucleotide exchange factor for ARF6 in chromaffin cells. Possible role in the regulated exocytotic pathway. J Biol Chem (2000) 1.09
Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity. J Biol Chem (2000) 1.09
Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int (1998) 1.09
Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem (1993) 1.08
Structural analysis of junctions formed between lipid membranes and several annexins by cryo-electron microscopy. J Mol Biol (1997) 1.08
Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J Biol Chem (2001) 1.08
A phase-contrast and immunofluorescence study of adrenal medullary chromaffin cells in culture: neurite formation, actin and chromaffin granule distribution. Cell Tissue Res (1981) 1.08
Evidence for tubulin-binding sites on cellular membranes: plasma membranes, mitochondrial membranes, and secretory granule membranes. J Cell Biol (1983) 1.07
Quantitative evaluation of the properties of a pyridazinyl GABA derivative (SR 95531) as a GABAA competitive antagonist. An electrophysiological approach. Brain Res (1988) 1.07
Correlation between catecholamine secretion from bovine isolated chromaffin cells and [3H]-ouabain binding to plasma membranes. Br J Pharmacol (1981) 1.06
Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability. Am J Physiol Cell Physiol (2001) 1.06
Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo. Oncogene (2010) 1.06
Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem (1996) 1.06
The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy. Eur J Nucl Med (1997) 1.05
Antibody-mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med (1988) 1.04
New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci (2005) 1.03
Identification of a potential effector pathway for the trimeric Go protein associated with secretory granules. Go stimulates a granule-bound phosphatidylinositol 4-kinase by activating RhoA in chromaffin cells. J Biol Chem (1998) 1.00
Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells. J Neurochem (1994) 1.00
The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization. Proc Natl Acad Sci U S A (2000) 1.00
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas. Invest New Drugs (2006) 1.00
Cultured glial cells express the SNAP-25 analogue SNAP-23. Glia (1999) 0.99
On the development of specific inhibitors of animal polyamine biosynthetic enzymes. Ital J Biochem (1976) 0.98
Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J Biol Chem (2000) 0.98
Freeze-fracture study of the chromaffin cell during exocytosis: evidence for connections between the plasma membrane and secretory granules and for movements of plasma membrane-associated particles. Cell Tissue Res (1979) 0.98
Chromaffin cell cytoskeleton: its possible role in secretion. Can J Biochem Cell Biol (1985) 0.98
The gene for SP-40,40, human homolog of rat sulfated glycoprotein 2, rat clusterin, and rat testosterone-repressed prostate message 2, maps to chromosome 8. Genomics (1991) 0.97
Differential expression of SNAP-25 isoforms and SNAP-23 in the adrenal gland. J Neurochem (1999) 0.96
Septal deviation in newborn infants. Int J Pediatr Otorhinolaryngol (1986) 0.96
Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance. Cereb Cortex (2006) 0.96
Presence of dynamin--syntaxin complexes associated with secretory granules in adrenal chromaffin cells. J Neurochem (2000) 0.96
Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion. Proc Natl Acad Sci U S A (1991) 0.96
Chromogranin A in the pancreatic islet: cellular and subcellular distribution. J Histochem Cytochem (1986) 0.96
Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells. Cell Death Differ (2005) 0.96
Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells. J Virol (1995) 0.95
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? Transplant Proc (1997) 0.94
Effects of collagenase on the release of [3H]-noradrenaline from bovine cultured adrenal chromaffin cells. Br J Pharmacol (1984) 0.94
Chromogranin A (CgA) in the gastro-entero-pancreatic (GEP) endocrine system. II. CgA in mammalian entero-endocrine cells. Histochemistry (1989) 0.94
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread. Oncogene (2009) 0.94
The 97-kD alpha-actinin-like protein in chromaffin granule membranes from adrenal medulla: evidence for localization on the cytoplasmic surface and for binding to actin filaments. Neuroscience (1983) 0.94
Secretory cell actin-binding proteins: identification of a gelsolin-like protein in chromaffin cells. J Cell Biol (1986) 0.94